Stock comparison
ELI LILLY & Co is 3.7x more valuable than Merck & Co., Inc. by market capitalization ($1.142 T vs $308.78 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 3.7x more valuable than Merck & Co., Inc. by market capitalization ($1.142 T vs $308.78 B).
Market value leader
LLY
ELI LILLY & Co is 3.7x more valuable than Merck & Co., Inc. by market capitalization ($1.142 T vs $308.78 B).
Revenue leader
LLY
MRK: $65.01B vs LLY: $65.18B.
Profit leader
LLY
MRK: $18.25B vs LLY: $20.64B.
Margin leader
LLY
MRK: 28.1% vs LLY: 31.7% net margin.
| Metric | MRK | LLY |
|---|---|---|
| Market cap | $308.78 B | $1.142 T |
| US-listed rank | #45 | #10 |
| Revenue (latest FY) | $65.01B | $65.18B |
| Net income (latest FY) | $18.25B | $20.64B |
| Net margin | 28.1% | 31.7% |
| P/E (trailing FY) | 16.9x | 55.3x |
| SEC filings | 998 | 995 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 3.7x more valuable than Merck & Co., Inc. by market capitalization ($1.142 T vs $308.78 B).
In their latest fiscal years, Merck & Co., Inc. reported $65.01B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Merck & Co., Inc. and ELI LILLY & Co, or browse the full rankings.